Healthful aging mediated by inhibition of oxidative stress

SF Vatner, J Zhang, M Oydanich, T Berkman… - Ageing Research …, 2020 - Elsevier
The progressive increase in lifespan over the past century carries with it some adversity
related to the accompanying burden of debilitating diseases prevalent in the older …

[HTML][HTML] Pathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: a review and synthesis

CY Santos, PJ Snyder, WC Wu, M Zhang… - Alzheimer's & Dementia …, 2017 - Elsevier
As the population ages due to demographic trends and gains in life expectancy, the
incidence and prevalence of dementia increases, and the need to understand the etiology …

A meta-analysis of cytokines in Alzheimer's disease

W Swardfager, K Lanctôt, L Rothenburg, A Wong… - Biological …, 2010 - Elsevier
BACKGROUND: Studies suggest that inflammation is involved in the neurodegenerative
cascade leading to Alzheimer's disease (AD) pathology and symptoms. This study sought to …

Monoaminergic neuropathology in Alzheimer's disease

G Šimić, MB Leko, S Wray, CR Harrington… - Progress in …, 2017 - Elsevier
None of the proposed mechanisms of Alzheimer's disease (AD) fully explains the distribution
patterns of the neuropathological changes at the cellular and regional levels, and their …

Biological potential of carbazole derivatives

A Głuszyńska - European journal of medicinal chemistry, 2015 - Elsevier
Carbazole skeleton is the key structural motif of many biologically active compounds
including synthetic and natural products. Over the past several years, a large number of …

Statins and cognitive function: a systematic review

K Richardson, M Schoen, B French… - Annals of internal …, 2013 - acpjournals.org
Background: Despite the US Food and Drug Administration (FDA) warning regarding
cognitive impairment, the relationship between statins and cognition remains unknown …

Blood–brain barrier permeable β-blockers linked to lower risk of Alzheimer's disease in hypertension

EE Beaman, AN Bonde, SMU Larsen, B Ozenne… - Brain, 2023 - academic.oup.com
Alzheimer's disease is a neurodegenerative disorder in which the pathological accumulation
of amyloid-β and tau begins years before symptom onset. Emerging evidence suggests that …

[HTML][HTML] Noradrenergic dysfunction in Alzheimer's disease

M Gannon, P Che, Y Chen, K Jiao… - Frontiers in …, 2015 - frontiersin.org
The brain noradrenergic system supplies the neurotransmitter norepinephrine throughout
the brain via widespread efferent projections, and plays a pivotal role in modulating …

Post-translational remodeling of ryanodine receptor induces calcium leak leading to Alzheimer's disease-like pathologies and cognitive deficits

A Lacampagne, X Liu, S Reiken, R Bussiere… - Acta …, 2017 - Springer
The mechanisms underlying ryanodine receptor (RyR) dysfunction associated with
Alzheimer disease (AD) are still not well understood. Here, we show that neuronal RyR2 …

Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County Dementia Progression …

JAT Tschanz, CD Corcoran, S Schwartz… - The American Journal of …, 2011 - Elsevier
Objectives Progression of Alzheimer dementia (AD) is highly variable. Most estimates derive
from convenience samples from dementia clinics or research centers where there is …